News
Improving Recognition, Diagnosis of Psychogenic Nonepileptic Seizures: Becky Tilahun, PhD
January 14th 2022The clinical psychologist at Cleveland Clinic provided insight on the tricky nature of diagnosing a patient with nonepileptic seizures and the difficult conversations that can ensue. [WATCH TIME: 3 minutes]
Age at MS Disease Onset Affects Pathophysiology, Gray and White Matter
January 14th 2022The authors noted that the findings indirectly support the use of highly effective disease-modifying treatments from the early stages of disease in those with pediatric-onset MS, even in the absence of persistent physical disability.
Disorders of Consciousness and COVID-19: David Fischer, MD
January 14th 2022The neurocritical care fellow at Massachusetts General Hospital and Brigham and Women’s Hospital discussed findings from a recent study that evaluated patients with COVID-19 and disorders of consciousness. [WATCH TIME: 3 minutes]
Evaluating Neurodegenerative Biomarkers in Hospitalized Patients With COVID-19, Alzheimer Disease
January 13th 2022Jennifer Frontera, MD, professor of neurology, NYU Langone Grossman School of Medicine, discussed findings from a recently published study investigating neurological complications in hospitalized patients with COVID-19.
Long-Term IV Edaravone Not Associated With Disease-Modifying Benefit in ALS
January 13th 2022Despite not providing additional, clinically relevant benefit for patients with amyotrophic lateral sclerosis as an add-on to standard therapy, the intravenous treatment was feasible and well tolerated.
Using Radiomics-Based MR Fingerprinting to Detect Focal Cortical Dysplasia: Irene Wang, PhD
January 13th 2022The research director and staff scientist at Cleveland Clinic’s Epilepsy Center provided insight on her study presented at AES 2021, which showed that MR fingerprinting can differentiate focal cortical dysplasia from healthy tissue. [WATCH TIME: 4 minutes]
Spasticity, Dystonia Commonly Under-Identified in Children With High Cerebral Palsy Risk
January 13th 2022Only 30% of the observed cohort of more than 150 children had their hypertonia type specified as spasticity and/or dystonia by age 5 years, highlighting a need for additional education efforts.
Using SAGE to Detect Mild Cognitive Impairment Earlier: Douglas Scharre, MD
January 13th 2022Outlining the findings from a recent study comparing SAGE to the Mini-Mental State Examination, the director of the Division of Cognitive and Memory Disorders at the Ohio State Wexner Medical Center stressed the importance of identifying patients at-risk for dementia early on. [WATCH TIME: 6 minutes]
SAGE and BrainTest for Cognitive Assessment and Clinical Trial Enrollment: Douglas Scharre, MD
January 12th 2022The director of the Division of Cognitive and Memory Disorders at the Ohio State Wexner Medical Center discussed benefits of both the pen-and-paper and digital assessments. [WATCH TIME: 7 minutes]
Clinical Experience as a Factor in the Inconsistencies of Migraine Care: Anne-Maree Kelly, MD
January 12th 2022The director of the Joseph Epstein Center for Emergency Medicine Research discussed whether years of experience causes variation in the way migraine is diagnosed and treated in an emergency department setting. [WATCH TIME: 2 minutes]
NeuroVoices: Irene Wang, PhD, on the Clinical Utility of MR Fingerprinting in Epilepsy
January 12th 2022The research director and staff scientist at Cleveland Clinic’s Epilepsy Center discussed why MR fingerprinting holds significant clinical potential in epilepsy and epilepsy-related disorders.
CMS Releases Proposed Decision for Aducanumab Coverage in Alzheimer Disease
January 11th 2022The Centers for Medicare and Medicaid Services issued a proposed decision memo detailing the coverage criteria for patients with Alzheimer disease to be covered by the federal health insurance platform when administered aducanumab (Aduhelm; Biogen).
Telemedicine’s Effect on Symptom Management, Care for Minority Populations in MS
January 11th 2022Mitzi Joi Williams, MD, founder and CEO of Joi Wellness Group Multiple Sclerosis Center, shared her thoughts on changes to the MS care model over the past year, as well as how the pandemic and telehealth have affected care for underrepresented populations.
New Data Boosts Efficacy Profile of gammaCore nVNS Device for Migraine Prevention
January 11th 2022The noninvasive vagus nerve stimulation device showed results consistent with what had been previously observed in the literature, with a particular benefit observed for those who have migraine with aura.
Development of SAGE for Early Dementia Detection: Douglas Scharre, MD
January 11th 2022The director of the Division of Cognitive and Memory Disorders at the Ohio State Wexner Medical Center discussed motivations behind creating the pen-and-paper test, as well as its digital companion. [WATCH TIME: 2 minutes]
Next Steps in Understanding Cognitive Decline in Aging MS: Dejan Jakimovski, MD, PhD
January 11th 2022The research assistant professor at the Buffalo Neuroimaging Analysis Center provided context on how different forms of multiple sclerosis impact cognitive decline in patients. [WATCH TIME: 4 minutes]
